830 related articles for article (PubMed ID: 11396755)
1. Methylene blue staining of dysplastic and nondysplastic Barrett's esophagus: an in vivo and ex vivo study.
Canto MI; Setrakian S; Willis JE; Chak A; Petras RE; Sivak MV
Endoscopy; 2001 May; 33(5):391-400. PubMed ID: 11396755
[TBL] [Abstract][Full Text] [Related]
2. A randomized, prospective cross-over trial comparing methylene blue-directed biopsy and conventional random biopsy for detecting intestinal metaplasia and dysplasia in Barrett's esophagus.
Ragunath K; Krasner N; Raman VS; Haqqani MT; Cheung WY
Endoscopy; 2003 Dec; 35(12):998-1003. PubMed ID: 14648410
[TBL] [Abstract][Full Text] [Related]
3. Comparison of methylene blue-directed biopsies and four-quadrant biopsies in the detection of high-grade intraepithelial neoplasia and early cancer in Barrett's oesophagus.
Gossner L; Pech O; May A; Vieth M; Stolte M; Ell C
Dig Liver Dis; 2006 Oct; 38(10):724-9. PubMed ID: 16911879
[TBL] [Abstract][Full Text] [Related]
4. Methylene blue chromoendoscopy for the detection of Barrett's esophagus in a Greek cohort.
Kouklakis GS; Kountouras J; Dokas SM; Molyvas EJ; Vourvoulakis GP; Minopoulos GI
Endoscopy; 2003 May; 35(5):383-7. PubMed ID: 12701007
[TBL] [Abstract][Full Text] [Related]
5. Screening for specialized columnar epithelium with methylene blue: chromoendoscopy in patients with Barrett's esophagus and a normal control group.
Kiesslich R; Hahn M; Herrmann G; Jung M
Gastrointest Endosc; 2001 Jan; 53(1):47-52. PubMed ID: 11154488
[TBL] [Abstract][Full Text] [Related]
6. A randomized comparison of methylene blue-directed biopsy versus conventional four-quadrant biopsy for the detection of intestinal metaplasia and dysplasia in patients with long-segment Barrett's esophagus.
Horwhat JD; Maydonovitch CL; Ramos F; Colina R; Gaertner E; Lee H; Wong RK
Am J Gastroenterol; 2008 Mar; 103(3):546-54. PubMed ID: 17970838
[TBL] [Abstract][Full Text] [Related]
7. Dysplasia in short-segment Barrett's esophagus: a prospective 3-year follow-up.
Sharma P; Morales TG; Bhattacharyya A; Garewal HS; Sampliner RE
Am J Gastroenterol; 1997 Nov; 92(11):2012-6. PubMed ID: 9362182
[TBL] [Abstract][Full Text] [Related]
8. Crystal violet chromoendoscopy with mucosal pit pattern diagnosis is useful for surveillance of short-segment Barrett's esophagus.
Amano Y; Kushiyama Y; Ishihara S; Yuki T; Miyaoka Y; Yoshino N; Ishimura N; Fujishiro H; Adachi K; Maruyama R; Rumi MA; Kinoshita Y
Am J Gastroenterol; 2005 Jan; 100(1):21-6. PubMed ID: 15654776
[TBL] [Abstract][Full Text] [Related]
9. Barrett's esophagus, high-grade dysplasia, and early adenocarcinoma: a pathological study.
Cameron AJ; Carpenter HA
Am J Gastroenterol; 1997 Apr; 92(4):586-91. PubMed ID: 9128304
[TBL] [Abstract][Full Text] [Related]
10. Prospective multivariate analysis of clinical, endoscopic, and histological factors predictive of the development of Barrett's multifocal high-grade dysplasia or adenocarcinoma.
Weston AP; Badr AS; Hassanein RS
Am J Gastroenterol; 1999 Dec; 94(12):3413-9. PubMed ID: 10606296
[TBL] [Abstract][Full Text] [Related]
11. Non-biopsy detection of intestinal metaplasia and dysplasia in Barrett's esophagus: a prospective multicenter study.
Sharma P; Marcon N; Wani S; Bansal A; Mathur S; Sampliner R; Lightdale C
Endoscopy; 2006 Dec; 38(12):1206-12. PubMed ID: 17163320
[TBL] [Abstract][Full Text] [Related]
12. Randomized crossover study that used methylene blue or random 4-quadrant biopsy for the diagnosis of dysplasia in Barrett's esophagus.
Lim CH; Rotimi O; Dexter SP; Axon AT
Gastrointest Endosc; 2006 Aug; 64(2):195-9. PubMed ID: 16860068
[TBL] [Abstract][Full Text] [Related]
13. Chromoendoscopy and magnification endoscopy for diagnosing esophageal cancer and dysplasia.
Connor MJ; Sharma P
Thorac Surg Clin; 2004 Feb; 14(1):87-94. PubMed ID: 15382312
[TBL] [Abstract][Full Text] [Related]
14. Proinflammatory cytokine and nuclear factor kappa-B expression along the inflammation-metaplasia-dysplasia-adenocarcinoma sequence in the esophagus.
O'Riordan JM; Abdel-latif MM; Ravi N; McNamara D; Byrne PJ; McDonald GS; Keeling PW; Kelleher D; Reynolds JV
Am J Gastroenterol; 2005 Jun; 100(6):1257-64. PubMed ID: 15929754
[TBL] [Abstract][Full Text] [Related]
15. [Surveillance of patients with Barrett's esophagus].
Endlicher E; Knüchel R; Messmann H
Z Gastroenterol; 2001 Aug; 39(8):593-600. PubMed ID: 11558064
[TBL] [Abstract][Full Text] [Related]
16. Survivin, a potential biomarker in the development of Barrett's adenocarcinoma.
Vallböhmer D; Peters JH; Oh D; Kuramochi H; Shimizu D; Demeester SR; Hagen JA; Chandrasoma PT; Danenberg KD; DeMeester TR; Danenberg P
Surgery; 2005 Oct; 138(4):701-6; discussion 706-7. PubMed ID: 16269299
[TBL] [Abstract][Full Text] [Related]
17. The development of dysplasia and adenocarcinoma during endoscopic surveillance of Barrett's esophagus.
Katz D; Rothstein R; Schned A; Dunn J; Seaver K; Antonioli D
Am J Gastroenterol; 1998 Apr; 93(4):536-41. PubMed ID: 9576444
[TBL] [Abstract][Full Text] [Related]
18. Advanced pathology under squamous epithelium on initial EMR specimens in patients with Barrett's esophagus and high-grade dysplasia or intramucosal carcinoma: implications for surveillance and endotherapy management.
Chennat J; Ross AS; Konda VJ; Lin S; Noffsinger A; Hart J; Waxman I
Gastrointest Endosc; 2009 Sep; 70(3):417-21. PubMed ID: 19555948
[TBL] [Abstract][Full Text] [Related]
19. Barrett's esophagus can and does regress after antireflux surgery: a study of prevalence and predictive features.
Gurski RR; Peters JH; Hagen JA; DeMeester SR; Bremner CG; Chandrasoma PT; DeMeester TR
J Am Coll Surg; 2003 May; 196(5):706-12; discussion 712-3. PubMed ID: 12742201
[TBL] [Abstract][Full Text] [Related]
20. Accuracy of endoscopic optical coherence tomography in the detection of dysplasia in Barrett's esophagus: a prospective, double-blinded study.
Isenberg G; Sivak MV; Chak A; Wong RC; Willis JE; Wolf B; Rowland DY; Das A; Rollins A
Gastrointest Endosc; 2005 Dec; 62(6):825-31. PubMed ID: 16301020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
